Drug Trial Radar · NCT06830629
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
74
Planned (sponsor's estimate)
Start
Feb 5, 2025
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Maze TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 68 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.
Conditions
- Proteinuric Kidney Disease
Interventions
MZE829Drug
Capsules for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability as assessed by incidence of adverse events (AEs)Time frame: Baseline to Week 12
Locations
79 sites in 3 countries. Site status is shown where the registry gives one.
Research Site
Decatur, Alabama · Recruiting
Research Site
Huntsville, Alabama · Recruiting
Research Site
Montgomery, Alabama · Recruiting
Research Site
Montgomery, Alabama · Recruiting
Research Site
Bloomfield, Connecticut · Recruiting
Research Site
Washington D.C., District of Columbia · Recruiting
Research Site
Atlantis, Florida · Recruiting
Research Site
Brandon, Florida · Recruiting
Research Site
Hollywood, Florida · Recruiting
Research Site
Melbourne, Florida · Recruiting
Research Site
Orlando, Florida · Recruiting
Research Site
Atlanta, Georgia · Recruiting
Research Site
College Park, Georgia · Recruiting
Research Site
Cordele, Georgia · Recruiting
Research Site
Macon, Georgia · Recruiting
Research Site
Riverdale, Georgia · Recruiting
Research Site
Riverdale, Georgia · Recruiting
Research Site
Savannah, Georgia · Recruiting
Research Site
Snellville, Georgia · Recruiting
Research Site
Chicago, Illinois · Recruiting
Research Site
Chicago, Illinois · Recruiting
Research Site
Evanston, Illinois · Recruiting
Research Site
Kansas City, Kansas · Recruiting
Research Site
Bowling Green, Kentucky · Recruiting
Research Site
Louisville, Kentucky · Recruiting
Research Site
Arnold, Maryland · Recruiting
Research Site
Lutherville, Maryland · Recruiting
Research Site
Oxon Hill, Maryland · Recruiting
Research Site
Dearborn, Michigan · Recruiting
Research Site
Flint, Michigan · Recruiting
Research Site
Pontiac, Michigan · Recruiting
Research Site
Saint Joseph, Michigan · Recruiting
Research Site
Minneapolis, Minnesota · Recruiting
Research Site
Tupelo, Mississippi · Recruiting
Research Site
City of Saint Peters, Missouri · Recruiting
Research Site
St Louis, Missouri · Recruiting
Research Site
Las Vegas, Nevada · Recruiting
Research Site
Jersey City, New Jersey · Recruiting
Research Site
Buffalo, New York · Recruiting
Research Site
Laurelton, New York · Recruiting
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.